This ‘living drug’ could change the course of autoimmune disease
Image: Science News
ad slot · in-content video 16:9
Coverage
Coverage
- If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.